Takuji Yamauchi Selected Research

Takuji Yamauchi Research Topics

5	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 03/2024 - 10/2009
5	Leukemia 01/2022 - 01/2016
3	Primary Myelofibrosis (Myelosclerosis) 11/2023 - 01/2016
3	Neoplasms (Cancer) 06/2023 - 01/2017
2	Infections 08/2022 - 01/2022
2	Cytomegalovirus Infections (Inclusion Disease) 08/2022 - 01/2022
2	Anemia 02/2022 - 12/2021
2	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2016 - 01/2010
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 06/2023
1	B-Cell Lymphoma (Lymphoma, B Cell) 06/2023
1	Diarrhea 06/2023
1	Edema (Dropsy) 06/2023
1	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 06/2023
1	Hyperplasia 02/2022
1	Carcinoma (Carcinomatosis) 01/2022
1	Stomach Neoplasms (Stomach Cancer) 01/2022
1	Connective Tissue Diseases (Connective Tissue Disease) 01/2020
1	Sarcoidosis (Schaumann Disease) 01/2020
1	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2020
1	Spinal Muscular Atrophy (Progressive Muscular Atrophy) 12/2018
1	Multiple Myeloma 04/2017
1	Chromosome Aberrations (Chromosome Abnormalities) 01/2017
1	Essential Thrombocythemia 01/2016
1	Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated) 01/2016
1	Lymphoma (Lymphomas) 01/2016
1	Disease Progression 01/2016
1	Aspergillosis 07/2011
1	T-Cell Lymphoma (Lymphoma, T Cell) 01/2010
1	Sepsis (Septicemia) 12/2009

1	Liposomes (Liposome)IBA 03/2024
1	Cytarabine (Cytosar-U)FDA LinkGeneric 03/2024
1	Daunorubicin (Cerubidine)FDA LinkGeneric 03/2024
1	ruxolitinibIBA 11/2023
1	tisagenlecleucelIBA 06/2023
1	Chimeric Antigen ReceptorsIBA 06/2023
1	CreatinineIBA 06/2023
1	letermovirIBA 08/2022
1	Immunoglobulin G (IgG)IBA 08/2022
1	purineIBA 01/2022
1	Tyrosine (L-Tyrosine)FDA Link 01/2022
1	gilteritinibIBA 01/2022
1	Cadherins (E-Cadherin)IBA 01/2022
1	Tyrosine Kinase InhibitorsIBA 01/2022
1	Immune Checkpoint ProteinsIBA 01/2020
1	Immune Checkpoint InhibitorsIBA 01/2020
1	5- ((1- (2,6- dichlorobenzyl)piperidin- 4- yl)methoxy)quinazoline- 2,4- diamineIBA 01/2019
1	EnzymesIBA 12/2018
1	RNA Precursors (Precursor, mRNA)IBA 12/2018
1	Proteasome InhibitorsIBA 04/2017
1	Bortezomib (Velcade)FDA Link 04/2017
1	Lenalidomide (CC 5013)FDA Link 04/2017
1	Immunomodulating AgentsIBA 04/2017
1	Thalidomide (Thalomid)FDA Link 04/2017
1	StilbenesIBA 01/2017
1	gnetin CIBA 01/2017
1	Monoclonal AntibodiesIBA 01/2016
1	CalreticulinIBA 01/2016
1	Janus Kinase 2IBA 01/2016
1	CCR4 ReceptorsIBA 01/2016
1	mogamulizumabIBA 01/2016
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2010
1	Gemtuzumab (Mylotarg)FDA Link 10/2009

5	Transplantation 08/2022 - 10/2009
3	Therapeutics 03/2024 - 07/2011
2	Hematopoietic Stem Cell Transplantation 01/2022 - 01/2016
1	Immunotherapy 06/2023
1	Cell Transplantation 08/2022
1	Blood Component Removal (Apheresis) 12/2021
1	Stem Cell Transplantation 07/2011
1	Cord Blood Stem Cell Transplantation 01/2010
1	Drug Therapy (Chemotherapy) 10/2009